Sign up to save your podcasts
Or
Share Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma
In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dosing in outpatient settings, and using tocilizumab and IVIG, among other management strategies.
Presenters:
Muhamed Baljevic, MD, FACP
Associate Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
Director, Multiple Myeloma Program
Director, Vanderbilt Amyloidosis Multidisciplinary Program (VAMP)
Co-Chair, Scientific Review Committee, VICC
Disease Team Lead, Plasma Cell Dyscrasias and Lymphomas
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Nashville, Tennessee
Jonathan Ticku, MD
Medical Oncologist and Hematologist
GU Oncology Lead, Mayo Clinic Health System
Assistant Professor of Oncology, Mayo Clinic
La Crosse, Wisconsin
Link to full program:
https://bit.ly/4u0xH6q
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Podcast on Apple Podcasts, YouTube Music, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
View all episodes
By Decera Clinical Education
4.9
1010 ratings
In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dosing in outpatient settings, and using tocilizumab and IVIG, among other management strategies.
Presenters:
Muhamed Baljevic, MD, FACP
Associate Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
Director, Multiple Myeloma Program
Director, Vanderbilt Amyloidosis Multidisciplinary Program (VAMP)
Co-Chair, Scientific Review Committee, VICC
Disease Team Lead, Plasma Cell Dyscrasias and Lymphomas
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Nashville, Tennessee
Jonathan Ticku, MD
Medical Oncologist and Hematologist
GU Oncology Lead, Mayo Clinic Health System
Assistant Professor of Oncology, Mayo Clinic
La Crosse, Wisconsin
Link to full program:
https://bit.ly/4u0xH6q
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Podcast on Apple Podcasts, YouTube Music, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More shows like Decera Clinical Education Oncology Podcast
View all
Stuff You Should Know
78,636 Listeners
Criminal
37,636 Listeners
Hidden Brain
43,528 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
506 Listeners
ASCO Daily News
57 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
The Daily
111,948 Listeners
ASCO Guidelines
47 Listeners
Blood Podcast
51 Listeners
Oncology Today with Dr Neil Love
59 Listeners
BioCentury This Week
34 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
46 Listeners